References
- D.J. Goldsetin, Beneficial health effects of modest weight loss. Int. J. Obesity., 16, 397-415 (1992).
- L.B. Cannistra, S.M. Davis and A.G. Bauman, Valvular heart disease associated with desfenfluramine, (letter). N. Engl. J. Med., 337, 636 (1997). https://doi.org/10.1056/NEJM199708283370912
- W.N. Kernan, C.M. Viscoli, L.M. Brass, J.P. Broderick, T.Brott, E. Feldmann, L.B. Morgenstern, J.L. Wilterdink and R.I.Horwitz, Phenylpropanolamine and the risk of hemorrhagicstroke. N. Engl. J. Med., 343, 1826-1832 (2000). https://doi.org/10.1056/NEJM200012213432501
- L. Sjostrom, J-P. Despres and A. Golay, Weight loss in overweight/obese dyslipidemia subjects treated with rimonbant: the RIO-Lipids trial. Int. J. Obesity., 28(s28) (2004).
- C.A. Luque and J.A. Rey, The discovery status of sibutramine as an antiobesity drug. Eur. J. of Pharmacol., 440, 119-128(2002). https://doi.org/10.1016/S0014-2999(02)01423-1
- R. Padwal, S.K. Li and D.C.W. Lau, Long term pharmacotherapy for overweight and obesity: A systemic review and meta analysis of randomized control trials. Int. J. Obesity., 27, 1437-1446 (2003). https://doi.org/10.1038/sj.ijo.0802475
- S.H. Kim, Y.M. Lee, H.J. Jee and C.M. Nam, Effect of sibutramine on weight loss and blood pressure: A meta analysis of controlled trials. Obesity Res., 9, 599-603 (2003).
- N. Finer, Pharmacotherapy of obesity. Best. Pract. Res. Clin. Endocrinol. Metab., 16, 717-742 (2002). https://doi.org/10.1053/beem.2002.0231
- Z. Abolfathi, J. Couture, F. Vallee, M. Lebel, M. Tanguay and E. Masson, A pilot study toevaluate the pharmacokinetics of sibutramine in healthy subjects under fasting and fed conditions. J. Pharm. Pharmaceut. Sci., 7, 345-349 (2004).
- A.C. Williams and B.W. Barry, Penetration enhancers. Adv. Drug Deliver. Rev., 56, 603-618 (2004). https://doi.org/10.1016/j.addr.2003.10.025
- Y.-J. Cho and H.-K. Choi, Enhancement of percutaneous absorption of ketoprofen: Effect of vehicles and adhesive matrix. Int. J. Pharm., 169, 95-104 (1998). https://doi.org/10.1016/S0378-5173(98)00115-X
- I.D. Hind, J.E. Mangham, S.P. Ghani, R.E. Haddock, C.J. Garratt and R.W. Jones, Sibutramine Pharmacokinetics in young and elderly healthy subjects. Eur. J. Clin. Pharmacol., 54, 847-849 (1999). https://doi.org/10.1007/s002280050565
- R. Freynhfen, P. Busche, R. Savatowski, C. Konrad and S. Grond, Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: A prospective, multicenter pilot study in outpatients with chronic pain. J. Pain Symptom Mgmt., 30, 289-297 (2005). https://doi.org/10.1016/j.jpainsymman.2005.03.015
- N.T. Hai, J. Kim, E-S. Park and S-C. Chi, Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine. Int. J. Pharm., 357, 55-60 (2008). https://doi.org/10.1016/j.ijpharm.2008.01.024
- S. Venkatraman and R. Gale, Skin adhesives and skin adhesion:1. Transdermal drug delivery systems. Biomaterials, 19, 1119-1136 (1998). https://doi.org/10.1016/S0142-9612(98)00020-9
- J.H. Kim, Y.J. Cho and H.K. Choi, Effect of vehicles and pressure sensitive adhesives on the permeation of tacrine across hairless mouse skin. Int. J. Pharm., 196, 105-113 (2000). https://doi.org/10.1016/S0378-5173(99)00449-4
- A.M. Wokovich, S. Prodduturi, W.H. Doub, A.S. Hussain and L.F. Buhse, Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. Eur. J. Pharm. Biopharm., 64, 1-8 (2006). https://doi.org/10.1016/j.ejpb.2006.03.009
- H.A. Cheong and H.K. Choi, Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines. Pharm. Res., 19, 1375-1380 (2002). https://doi.org/10.1023/A:1020367212307
- H.M. Ki, and H.K. Choi, The effects of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam. Arch. Pharm. Res., 30, 215-221 (2007). https://doi.org/10.1007/BF02977697
- K.A. Walters and J. Hadgraft, "Pharmaceutical skin penetration enhancement". Marcel Dekker, Inc.: New York, 113-138 (1993).
- E.S. Park, S.Y. Chang, M.K. Hahn and S.C. Chi, Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen. Int. J. Pharm., 209, 109-119 (2000). https://doi.org/10.1016/S0378-5173(00)00559-7
- F. Bucaretchi, E.M.D. Capitani, S.M. Mello, F. Lanaro, R.F. Barros, L.C.R. Fernandes and J.L.D. Costa, Serotonin syndrome following sibutramine poisoning in a child, with sequential quantification of sibutramine and its primary and secondary amine metabolites in plasma. Clin. Toxicol., 47, 598-601 (2009). https://doi.org/10.1080/15563650903018603